Edwin J C G van den Oord

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Jeffrey A Lieberman, Patrick F Sullivan, Robert E Vann, 2011, Neuropsychopharmacology.